| Literature DB >> 23239969 |
Luciano Daliento1, Lucia Dal Bianco, Francesco Bagato, Eleonora Secco, Berardo Sarubbi, Elisa Mazzotti, Barbara Bauce, Giulio Rizzoli.
Abstract
BACKGROUND: The aim of this study was to describe gender differences in patients operated on for TOF and to define the impact of pregnancy in late post-surgical follow-up in women.Entities:
Mesh:
Year: 2012 PMID: 23239969 PMCID: PMC3519776 DOI: 10.1371/journal.pone.0049729
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Patients enrolled.
| ALL | MEN | WOMEN | NO PREGNANT | PREGNANT | P | |
|
| 145 | 66 | 79 | 38 | 41 | |
| (100%) | (45.52%) | (54.48%) | p = NS | |||
| (100%)* | p* = NS | |||||
| (48.10%)* | (51.90%)* | |||||
|
| 37.72±10.40 | 37.32±10.27 | 38.07±10.49 | 35.85±10.54 | 40.16±10.00 | |
| p = NS | ||||||
| p* = NS |
(*) = Referred only to women population (N = 79).
Surgical data.
| ALL | MEN | WOMEN | NO PREGNANT | PREGNANT | P | |
|
| 57 | 27 | 30 | 13 | 17 | |
| (100%) | (47.37%) | (52.63%) | p = NS | |||
| (100%)* | p* = NS | |||||
| (43.33%)* | (56.67%)* | |||||
|
| 2.11±3.11 | 2.41±3.97 | 1.83±2.02 | 1.16±1.84 | 2.34±2.01 | |
|
| p = NS | |||||
| p* = NS | ||||||
|
| 7.61±8.25 | 7.51±7.70 | 7.70±8.67 | 5.68±6.03 | 9.56±10.20 | |
|
| p = NS | |||||
| p* = NS | ||||||
|
| 30.11±7.66 | 29.81±7.14 | 30.35±8.06 | 30.17±7.094 | 30.60±8.17 | |
|
| p = NS | |||||
| p* = NS |
(*) = Referred only to women population (N = 30).
Figure 1Demographic representation of women population based on pregnancies history.
Figure 2Post-operative pregnancy failure function.
Figure 3Global analysis of 68 pregnancies.
PM and ICD.
| ALL | MEN | WOMEN | NO PREGNANT | PREGNANT | P | |
|
| 3 | 1 | 2 | 2 | 0 | |
| (2.07%) | (0.69%) | (1.38%) | p = NS | |||
| (2.53%)* | p* = NS | |||||
| (2.53%)* | (0.00%)* | |||||
|
| 8 | 5 | 3 | 2 | 1 | |
| (5.52%) | (3.45%) | (2.07%) | ||||
| (3.80%)* | p = NS | |||||
| p* = NS | ||||||
| (2.53%)* | (1.28%)* | |||||
|
| 33.71±11.65 | 28.43±10.92 | 44.28±1.11 | 44.28±1.11 | – | P<0.0001 p* = – |
(*) = Referred only to women population (N = 79).
Comorbidity.
| ALL | MEN | WOMEN | NO PREGNANT | PREGNANT | P | |
|
| 50 | 19 | 31 | 16 | 15 | |
|
| (34.48%) | (13.10%) | (21.38%) | p = 0.0001 | ||
| (39.24%)* | p* = NS | |||||
| (20.25%)* | (18.99%)* | |||||
|
| 10 | 2 | 8 | 3 | 5 | |
|
| (6.90%) | (1.38%) | (5.52%) | p = 0.03 | ||
|
| (10.12%)* | p* = NS | ||||
|
| (3.80%)* | (6.32%)* |
(*) = Referred only to women population (N = 79).
Figure 4Reoperation-free survival according to sex.
ECG analysis at the last follow-up.
| ALL | MEN | WOMEN | NO PREGNANT | PREGNANT | P | |
|
| 78 | 38 | 40 | 18 | 22 | |
| (100%) | (48,72%) | (51,28%) | p = NS | |||
| (100%)* | (45,00%)* | (55,00%)* | p* = NS | |||
|
| 156,75±27,41 | 163,47±27,27 | 149,13±25,52 | 150,08±24,23 | 148,41±26,44 | |
|
| (N = 64) | (N = 34) | (N = 30) | (N = 13) | (N = 17) | p = 0,017 |
| p* = NS | ||||||
|
| 4 | 2 | 2 | 1 | 1 | |
| (5,33%) | (2,13%) | (2,13%) | ||||
| (N = 75) | (N = 38) | (5,41%) | (2,70%) | (2,70%) | p = NS | |
| (N = 37) | (N = 16) | (N = 21) | p* = NS | |||
|
| 68 | 34 | 34 | 15 | 19 | |
| (90,67%) | (36,17%) | (36,17%) | ||||
| (N = 75) | (N = 38) | (91,89%) | (40,54%) | (51,35%) | p = NS | |
| (N = 37) | (N = 16) | (N = 21) | p* = NS | |||
|
| 439,53±49 | 446,76±56,85 | 431,53±36,91 | 435,78±47,56 | 427,70±22,85 | |
|
| (N = 40) | (N = 21) | (N = 19) | (N = 9) | (N = 10) | p = NS |
| p* = NS | ||||||
|
| 469,92±38,32 | 482,31±42,05 | 457,54±29,37 | 453,17±31,92 | 461,29±26,42 | |
|
| (N = 26) | (N = 13) | (N = 13) | (N = 6) | (N = 7) | p = 0,09 |
| p* = NS | ||||||
|
| 56,21±16,92 | 60,29±19,74 | 51,88±11,84 | 51,25±13,64 | 52,50±9,68 | |
|
| (N = 33) | (N = 17) | (N = 16) | (N = 8) | (N = 8) | p = NS |
| p* = NS |
(*) = Referred only to women population (N = 79).
Left ventricular size and function (LV EDV = Left Ventricular End-Diastolic Volume. LV EF = Left Ventricular Ejection Fraction.
| ALL | MEN | WOMEN | NO PREGNANT | PREGNANT | P | |
|
| p = 0.0001 | |||||
| (ml/m2) | 59,01±16.28 | 65.55±19.11 | 53.42±10.57 | 52.51±9.51 | 54.25±11.39 | p* = NS |
| 117 | 43 | 74 | 37 | 37 | ||
| Normal EDV | (80.69%) | (29.66%) | (51.03%) | p = 0.0001 | ||
| (≤75 ml/m2) | (93.67%)* | (46.84%)* | (46.84%)* | p* = NS | ||
| Moderately enlarged LV | 15 | 14 | 1 | 0 | 1 | |
| (87–96 ml/m2) | (10.34%) | (9.65%) | (0.69%) | p = 0.0001 | ||
| (1.27%)* | (0.0%)* | (1.27%)* | p* = NS | |||
|
| 58.45±5.67 | 56.97±6 | 59.69±5.06 | 60.5±4.89 | 58.93±5.09 | p = 0.003 |
| p* = NS | ||||||
| Normal EF | 127 | 54 | 73 | 36 | 37 | |
| (≥55%) | (87.58%) | (37.24%) | (50.34%) | p = 0.07 | ||
| (92.41%)* | (45.57%)* | (46.84%) | p* = NS | |||
| Moderately reduced EF | 5 | 4 | 1 | 0 | 1 | |
| (44–30%) | (3.45%) | (2.76%) | (0.69%) | p = NS | ||
| (1.27%)* | (0.0%)* | (1.27%)* | p* = NS |
(*) = Referred only to women population (N = 79).
Right ventricular size and function. RV EDA = Right Ventricular End-Diastolic Area. RV EFA = Right Ventricular Ejection Fraction Area.
| ALL | MEN | WOMEN | NO PREGNANT | PREGNANT | P | |
|
| 35.96±9.91 | 39.62±10.06 | 32.30±8.27 | 30.87±7.15 | 33.67±9 | p = 0.0002 |
| (cm2) | p* = NS | |||||
| Normal EDA | 10 | 0 | 10 | 7 | 3 | |
| (≤28 cm2) | (6.90%) | (0.00%) | (6.90%) | p = 0.0001 | ||
| (12.66%)* | (8.86%)* | (3.80%)* | p* = NS | |||
| Moderately enlarged RV | 29 | 11 | 18 | 7 | 11 | |
| (33–37 cm2) | (20.00%) | (7.59%) | (12.41%) | p = NS | ||
| (122.78%)* | (8.86%)* | (13.92%)* | p* = NS | |||
| Severely enlarged RV | 35 | 24 | 11 | 6 | 5 | |
| (≥38 cm2) | (66.20%) | (16.55%) | (7.59%) | p = 0.01 | ||
| (13.92%)* | (7.59%)* | (6.33%)* | p* = NS | |||
|
| 34.54±7.63 | 33.89±7.22 | 35.09±7.91 | 36.66±8.38 | 33.63±7.15 | p = NS |
| p* = 0.08 | ||||||
| Normal EFA | 96 | 45 | 51 | 27 | 24 | |
| (≥32%) | (66.20%) | (31.03%) | (35.17%) | p = NS | ||
| (64.56%)* | (34.18%)* | (30.38%) | p* = NS | |||
| Moderately reduced EFA | 9 | 6 | 3 | 1 | 2 | |
| (18–24%) | (6.21%) | (4.14%) | (2.07%) | p = NS | ||
| (3.80%)* | (1.27%)* | (2.53%)* | p* = NS | |||
| Severely reduced EFA | 2 | 1 | 1 | 0 | 1 | p = NS |
| (≤17%) | (1.38%) | (0.69%) | (0.69%) | p* = NS | ||
| (1.27%)* | (0.0%)* | (1.27%)* |
(*) = referred only to women population (N = 79).
Figure 5Time related arrhythmia development according to sex of the patient and pregnancy.
Figure 6Probability of severe arrhythmia according to results of multivariate analysis.